These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients. Lee AC; Mosaed S; Weinreb RN; Kripke DF; Liu JH Ophthalmology; 2007 Apr; 114(4):666-70. PubMed ID: 17188360 [TBL] [Abstract][Full Text] [Related]
29. January consultation #6. Maria Fea A J Cataract Refract Surg; 2020 Jan; 46(1):158. PubMed ID: 32510886 [No Abstract] [Full Text] [Related]
30. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368 [TBL] [Abstract][Full Text] [Related]
31. [Neuroprotection and vasoprotection in glaucoma]. Ignat F Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092 [No Abstract] [Full Text] [Related]
32. Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma. Francis BA; Ianchulev T; Schofield JK; Minckler DS Am J Ophthalmol; 2005 Sep; 140(3):524-5. PubMed ID: 16139003 [TBL] [Abstract][Full Text] [Related]
33. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E Curr Opin Ophthalmol; 2004 Apr; 15(2):102-6. PubMed ID: 15021220 [TBL] [Abstract][Full Text] [Related]
34. Trabeculectomy: more effective at causing cataract surgery than lowering intraocular pressure? Jampel H Ophthalmology; 2009 Feb; 116(2):173-4. PubMed ID: 19187821 [No Abstract] [Full Text] [Related]
35. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution. Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081 [TBL] [Abstract][Full Text] [Related]
36. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191 [TBL] [Abstract][Full Text] [Related]
37. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Bengtsson B; Leske MC; Hyman L; Heijl A; Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736 [TBL] [Abstract][Full Text] [Related]
38. Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. Danesh-Meyer HV; Papchenko T; Tan YW; Gamble GD Ophthalmology; 2008 Sep; 115(9):1566-70. PubMed ID: 18321584 [TBL] [Abstract][Full Text] [Related]
39. Choroidal detachment with topical latanoprost after glaucoma filtration surgery. Sodhi PK; Sachdev MS; Gupta A; Verma LK; Ratan SK Ann Pharmacother; 2004 Mar; 38(3):510-1. PubMed ID: 14970375 [No Abstract] [Full Text] [Related]